TP53 and neoplasm: Emerging studies have begun to classify mutations in TP53 and proposed the concept of oncomorphic/gain of function (GOF) and loss of function (LOF) mutations, both of which are tumor‐promoting due to distinct mechanisms.11, 12, 13